A Safety, Tolerability and Efficacy Study With QBW251 in COPD Patients With QBW251
Status:
Completed
Trial end date:
2017-01-23
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy, safety and tolerability of multiple doses of QBW251 vs placebo
administered orally, on airway function, lung volume, and quality of life in patients with
chronic obstructive pulmonary disease (COPD)